Abstract PO1-01-03: Pathological Response According to Early Metabolic Remission in an Interim FDG-PET Scan and to Tumor Infiltrating Lymphocytes - A Secondary Analysis of the Phase II Trial ABCSG 52/ATHENE Investigating Atezolizumab in Early HER2+ BC
Cancer Research(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined